Cargando…
Clinical Outcome of Eradication Therapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma according to H. pylori Infection Status
Background. To evaluate the long-term outcome of H. pylori eradication therapy for gastric MALT lymphoma according to the presence of H. pylori infection. Methods. We retrospectively reviewed the medical records of patients between January 2001 and June 2014. The clinicopathologic characteristics an...
Autores principales: | Kim, Ju Seok, Kang, Sun Hyung, Moon, Hee Seok, Sung, Jae Kyu, Jeong, Hyun Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789472/ https://www.ncbi.nlm.nih.gov/pubmed/27034656 http://dx.doi.org/10.1155/2016/6794848 |
Ejemplares similares
-
Treatment Outcome for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma according to Helicobacter pylori Infection Status: A Single-Center Experience
por: Ryu, Kwang Duck, et al.
Publicado: (2014) -
Helicobacter pylori Eradication Therapy Is Effective as the Initial Treatment for Patients with H. pylori-Negative and Disseminated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
por: Gong, Eun Jeong, et al.
Publicado: (2016) -
Successful Endoscopic Resection of Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Unresponsive to Helicobacter pylori Eradication Therapy
por: Choi, Jeongmin
Publicado: (2022) -
Low Grade Gastric Mucosa-associated Lymphoid Tissue Lymphoma: Clinicopathological Factors Associated with Helicobacter pylori Eradication and Tumor Regression
por: Choi, Yoon Jin, et al.
Publicado: (2011) -
Clinical efficacy of the modified Helicobacter pylori eradication therapy for Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: a meta analysis
por: Xie, Ya-Lin, et al.
Publicado: (2020)